Lista de obras - Pablo Bellot - Dominio Público Uruguay

Absent in melanoma 2 triggers a heightened inflammasome response in ascitic fluid macrophages of patients with cirrhosis

artículo científico publicado en 2014

Acute effects of dipyrone on renal function in patients with cirrhosis: a randomized controlled trial

artículo científico publicado en 2014

Acute hepatitis in a patient with cirrhosis and hepatocellular carcinoma treated with sorafenib.

artículo científico publicado en 2009

Bifidobacterium pseudocatenulatum CECT7765 induces an M2 anti-inflammatory transition in macrophages from patients with cirrhosis.

artículo científico publicado en 2015

Clinical and epidemiological characteristics of pyogenic liver abscess in people 65 years or older versus people under 65: a retrospective study

artículo científico publicado en 2017

Comparison of the in vitro susceptibility of rifaximin versus norfloxacin against multidrug resistant bacteria in a hospital setting. A proof-of-concept study for use in advanced cirrhosis

scientific article published on 01 April 2015

Evaluation of regional hepatic perfusion (RHP) by contrast-enhanced ultrasound in patients with cirrhosis.

artículo científico publicado en 2010

Grade of soluble inflammatory response is mainly affected by circulating bacterial DNA concentrations in cirrhosis.

artículo científico publicado en 2016

Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity.

artículo científico publicado en 2006

Interleukin-10-mediated heme oxygenase 1-induced underlying mechanism in inflammatory down-regulation by norfloxacin in cirrhosis

artículo científico publicado en 2011

Lactulose reduces bacterial DNA translocation, which worsens neurocognitive shape in cirrhotic patients with minimal hepatic encephalopathy

artículo científico publicado en 2016

Large spontaneous splenorenal shunt as a cause of chronic hepatic encephalopathy

artículo científico publicado en 2004

NCX-1000, a nitric oxide-releasing derivative of UDCA, does not decrease portal pressure in patients with cirrhosis: results of a randomized, double-blind, dose-escalating study.

artículo científico publicado en 2009

Norfloxacin is more effective than Rifaximin in avoiding bacterial translocation in an animal model of cirrhosis.

artículo científico publicado en 2017

Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study

artículo científico publicado en 2007

Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications.

artículo científico publicado en 2012

Presence of bacterial-DNA in cirrhosis identifies a subgroup of patients with marked inflammatory response not related to endotoxin

artículo científico publicado en 2007

Primary prophylaxis of esophageal variceal bleeding in cirrhosis.

artículo científico publicado en 2008

Serum and ascitic fluid bacterial DNA: a new independent prognostic factor in noninfected patients with cirrhosis

artículo científico publicado en 2008

The existence of a relationship between increased serum alanine aminotransferase levels detected in premarketing clinical trials and postmarketing published hepatotoxicity case reports.

artículo científico publicado en 2010

The use of β-blockers is associated with a lower risk of developing hepatocellular carcinoma in patients with cirrhosis.

artículo científico publicado en 2016

Treatment of severe recurrent hepatitis C after liver transplantation in HIV infected patients using sofosbuvir-based therapy

artículo científico publicado en 2016

Use of proton pump inhibitors decrease cellular oxidative burst in patients with decompensated cirrhosis

artículo científico publicado en 2015

[Bacterial translocation in cirrhosis]

scientific article published on 01 October 2008

[Current problems in the prevention and treatment of infections in patients with cirrhosis]

scientific article published on 04 May 2010

[Treatment of refractory hepatic encephalopathy associated with insertion of a transjugular intrahepatic portosystemic shunt through new endovascular techniques: a case report]

artículo científico publicado en 2011

[Usefulness of tomographic computer colonography for colorectal polyp detection].

artículo científico publicado en 2004

Lista de obras de Pablo Bellot

Absent in melanoma 2 triggers a heightened inflammasome response in ascitic fluid macrophages of patients with cirrhosis

Acute effects of dipyrone on renal function in patients with cirrhosis: a randomized controlled trial

Acute hepatitis in a patient with cirrhosis and hepatocellular carcinoma treated with sorafenib.

Bifidobacterium pseudocatenulatum CECT7765 induces an M2 anti-inflammatory transition in macrophages from patients with cirrhosis.

Clinical and epidemiological characteristics of pyogenic liver abscess in people 65 years or older versus people under 65: a retrospective study

Comparison of the in vitro susceptibility of rifaximin versus norfloxacin against multidrug resistant bacteria in a hospital setting. A proof-of-concept study for use in advanced cirrhosis

Evaluation of regional hepatic perfusion (RHP) by contrast-enhanced ultrasound in patients with cirrhosis.

Grade of soluble inflammatory response is mainly affected by circulating bacterial DNA concentrations in cirrhosis.

Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity.

Interleukin-10-mediated heme oxygenase 1-induced underlying mechanism in inflammatory down-regulation by norfloxacin in cirrhosis

Lactulose reduces bacterial DNA translocation, which worsens neurocognitive shape in cirrhotic patients with minimal hepatic encephalopathy

Large spontaneous splenorenal shunt as a cause of chronic hepatic encephalopathy

NCX-1000, a nitric oxide-releasing derivative of UDCA, does not decrease portal pressure in patients with cirrhosis: results of a randomized, double-blind, dose-escalating study.

Norfloxacin is more effective than Rifaximin in avoiding bacterial translocation in an animal model of cirrhosis.

Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study

Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications.

Presence of bacterial-DNA in cirrhosis identifies a subgroup of patients with marked inflammatory response not related to endotoxin

Primary prophylaxis of esophageal variceal bleeding in cirrhosis.

Serum and ascitic fluid bacterial DNA: a new independent prognostic factor in noninfected patients with cirrhosis

The existence of a relationship between increased serum alanine aminotransferase levels detected in premarketing clinical trials and postmarketing published hepatotoxicity case reports.

The use of β-blockers is associated with a lower risk of developing hepatocellular carcinoma in patients with cirrhosis.

Treatment of severe recurrent hepatitis C after liver transplantation in HIV infected patients using sofosbuvir-based therapy

Use of proton pump inhibitors decrease cellular oxidative burst in patients with decompensated cirrhosis

[Bacterial translocation in cirrhosis]

[Current problems in the prevention and treatment of infections in patients with cirrhosis]

[Treatment of refractory hepatic encephalopathy associated with insertion of a transjugular intrahepatic portosystemic shunt through new endovascular techniques: a case report]

[Usefulness of tomographic computer colonography for colorectal polyp detection].